Article
A novel activating somatic mutation in EPAS1, coding for HIF-2α, in a patient with a paraganglioma and sickle cell disease.
Archives of endocrinology and metabolism - 7 Apr 2026
Shekhda Kalyan Mansukhbhai, Iyer Rishi, Robledo Mercedes, Nara Viktorija, Luong Tu Vinh, Caplin Martyn, Grossman Ashley B
Abstract excerpt
Pheochromocytomasand paragangliomas (collectively referred as PPGLs) are highly heritable neoplasms arise from chromaffin cells of neural crest tissues; 40% of patients with PPGLs harbour germline pathogenic variants (PV), which up to 45% of patients exhibit somatic mutations in similar susceptibility genes. Endothelial PAS domain-containing protein-1 [also known as hypoxia inducible factor-2α, HIF-2α] is encoded...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
